Lexaria Bioscience Corp. (LEXX)
NASDAQ · Healthcare
Lexaria Bioscience Corp. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lexaria Bioscience Corp. revenue for the quarter ending February 28, 2026 was 20000, a 88.51% decrease year-over-year.
- Lexaria Bioscience Corp. revenue for the twelve months ending February 28, 2026 was 368000, a 34.78% decrease year-over-year.
- Lexaria Bioscience Corp. annual revenue for 2025 was 705923, a 52.05% increase from 2024.
- Lexaria Bioscience Corp. annual revenue for 2024 was 464278, a 105.24% increase from 2023.
- Lexaria Bioscience Corp. annual revenue for 2023 was 226208, a 11.43% decrease from 2022.
- Lexaria Bioscience Corp. annual revenue for 2022 was 255397.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lexaria Bioscience Corp. Earnings — FAQ
Lexaria Bioscience Corp. (LEXX) earnings over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LEXX's earnings history?
The chart and table above show Lexaria Bioscience Corp.'s earnings by year and by quarter, including the growth rate.